Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Unlimited Watchlists, Portfolios, Screeners, and other Barchart tools. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Ekso Bionics Holdings Inc (EKSO)

Ekso Bionics Holdings Inc (EKSO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 17,479
  • Shares Outstanding, K 13,142
  • Annual Sales, $ 11,250 K
  • Annual Income, $ -9,760 K
  • 60-Month Beta 1.59
  • Price/Sales 1.51
  • Price/Cash Flow N/A
  • Price/Book 0.59
Trade EKSO with:

Options Overview Details

View History
  • Implied Volatility 163.24% ( -126.22%)
  • Historical Volatility 84.72%
  • IV Percentile 81%
  • IV Rank 27.00%
  • IV High 531.44% on 11/22/22
  • IV Low 27.03% on 10/18/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 4
  • Volume Avg (30-Day) 42
  • Put/Call OI Ratio 0.34
  • Today's Open Interest 1,021
  • Open Int (30-Day) 1,037

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -0.22
  • Number of Estimates 1
  • High Estimate -0.22
  • Low Estimate -0.22
  • Prior Year -0.23
  • Growth Rate Est. (year over year) +4.35%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.0300 +23.55%
on 11/30/22
1.5200 -16.28%
on 11/08/22
-0.1974 (-13.43%)
since 11/07/22
3-Month
1.0300 +23.55%
on 11/30/22
2.3200 -45.15%
on 09/09/22
-0.9124 (-41.76%)
since 09/07/22
52-Week
1.0300 +23.55%
on 11/30/22
3.4900 -63.54%
on 12/08/21
-2.0274 (-61.44%)
since 12/07/21

Most Recent Stories

More News
Ekso Bionics (EKSO) Reports Q3 Loss, Lags Revenue Estimates

Ekso Bionics (EKSO) delivered earnings and revenue surprises of -37.50% and 7.01%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

EKSO : 1.2726 (-4.32%)
SWAV : 233.60 (+0.39%)
Ekso Bionics: Q3 Earnings Snapshot

Ekso Bionics: Q3 Earnings Snapshot

EKSO : 1.2726 (-4.32%)
Integra LifeSciences (IART) Beats Q3 Earnings and Revenue Estimates

Integra (IART) delivered earnings and revenue surprises of 19.44% and 1.96%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

IART : 55.61 (+1.57%)
EKSO : 1.2726 (-4.32%)
Ekso Bionics (EKSO) Reports Q2 Loss, Misses Revenue Estimates

Ekso Bionics (EKSO) delivered earnings and revenue surprises of 4.17% and 0.72%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

EKSO : 1.2726 (-4.32%)
PEN : 220.00 (+1.85%)
Ekso Bionics Reports Second Quarter 2022 Results

RICHMOND, Calif., July 28, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton...

EKSO : 1.2726 (-4.32%)
Ekso Bionics to Report Second Quarter 2022 Financial Results on July 28

RICHMOND, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton...

EKSO : 1.2726 (-4.32%)
Ekso Bionics Receives FDA Clearance to Market its EksoNR™ Robotic Exoskeleton for Use with Multiple Sclerosis Patients

First FDA Cleared Exoskeleton for Rehabilitation Use in Patients with Multiple Sclerosis RICHMOND, Calif., June 13, 2022 (GLOBE NEWSWIRE) -- Ekso...

EKSO : 1.2726 (-4.32%)
Ekso Bionics Appoints Jerome Wong Interim Chief Financial Officer

RICHMOND, Calif., May 26, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton...

EKSO : 1.2726 (-4.32%)
Ekso Bionics (EKSO) Could Find Support Soon, Here's Why You Should Buy the Stock Now

Ekso Bionics (EKSO) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall...

EKSO : 1.2726 (-4.32%)
Ekso Bionics (EKSO) Reports Q1 Loss, Lags Revenue Estimates

Ekso Bionics (EKSO) delivered earnings and revenue surprises of 12.20% and 19.78%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

EKSO : 1.2726 (-4.32%)
SMLR : 30.55 (+0.79%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Ekso Bionics Holdings, Inc. is engaged in designing, developing and selling wearable robots or exoskeletons for the medical, military, industrial and consumer markets. The company's operating segment consists of Engineering Services and Medical segments. It operates primarily in North America, Western...

See More

Key Turning Points

3rd Resistance Point 1.4384
2nd Resistance Point 1.4042
1st Resistance Point 1.3384
Last Price 1.2726
1st Support Level 1.2384
2nd Support Level 1.2042
3rd Support Level 1.1384

See More

52-Week High 3.4900
Fibonacci 61.8% 2.5503
Fibonacci 50% 2.2600
Fibonacci 38.2% 1.9697
Last Price 1.2726
52-Week Low 1.0300

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar